(MENAFN- PR Newswire) SAN DIEGO, Jan. 25, 2023 /PRNewswire/ -- Juno DiagnosticsTM (JunoDxTM), a company focused on bringing vital health information to patients by improving access, affordability, and transparency, today announced it will participate at the Precision Medicine World Conference (PMWC), held January 25-27, 2023, in Santa Clara, CA.
Dr. Mathias Ehrich, Chief Medical Officer and co-founder at Juno Diagnostics, will present a company overview on Friday, January 27th, at 10:00 am PT. In addition, Todd Whitson, Executive President of Business Development and Commercial Operations, will also be attending the conference and will be available for meetings throughout the event.
About Juno Diagnostics TM
Juno DiagnosticsTM is a category-defining health company bringing vital prenatal health information to patients by combining access, affordability, and transparency. The Company's lead product, Juno HazelTM, is a non-invasive prenatal screening (NIPS) solution that simplifies sample collection and improves access to high-quality genetic testing results without the high cost, long lead times, and phlebotomy requirements of traditional NIPS.
For more information, visit
and engage with us on LinkedIn.
Investor and Media Contact:
Amy Conrad
Juniper Point
[email protected]
858-366-3243
SOURCE Juno Diagnostics
MENAFN25012023003732001241ID1105476165
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.